Indications
Prophylaxis of transplant rejection in adult and paediatric, kidney, liver or heart allograft recipients. Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult and paediatric patients.
Composition
- Active substance
- tacrolimus
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Modigraf
- Active substance
- tacrolimus
- ATC code
- L04AD02
- Therapeutic area
- Graft Rejection
- Marketing authorisation holder
- Astellas Pharma Europe B.V.
- Status